(NEW YORK)Endo Pharmaceuticals said Tuesday its Chief Financial Officer Charles Rowland has resigned to pursue other interests. Rowland's resignation takes effect immediately, and the compan...READ MORE
(NEW YORK)Shares of Alpharma Inc. surged Friday, as investors wagered the stock is worth more than the $33 per share buyout price offered by King Pharmaceuticals Inc. in its $1.4 billion cas...READ MORE
(WASHINGTON)Endo Pharmaceuticals spent $410,000 lobbying in the first quarter on drug and patent issues, according to a recent government disclosure. The Chadds Ford, Penn.-based company oppos...READ MORE
(NEW YORK)A Roth Capital Partners analyst downgraded shares of Endo Pharmaceuticals Holdings Inc. Friday, saying weak sales of key drugs will prevent the stock from rising much higher.READ MORE
(NEW YORK)Drug maker Endo Pharmaceuticals Holdings Inc. said Wednesday its board will nominate William F. Spengler to the board at its annual meeting as part of an agreement with shareholder...READ MORE
(CHADDS FORD, Pa.)Endo Pharmaceuticals Holdings Inc., which makes pain meds Percocet, Opana and the Lidoderm patch, said Wednesday David A. Lee has resigned as chief scientific officer to devote mor...READ MORE
(CHADDS FORD, Pa.)
Endo Pharmaceuticals Holdings Inc. said Wednesday it will offer about $345 million in senior notes due 2015, and use the proceeds to help pay for a convertible hedge note deal.
T...READ MORE